{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:40:52Z","timestamp":1792690852929,"version":"4.5.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T00:00:00Z","timestamp":1581033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0228486","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T13:28:40Z","timestamp":1581082120000},"page":"e0228486","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":31,"title":["Bevacizumab for treating Hereditary Hemorrhagic Telangiectasia patients with severe hepatic involvement or refractory anemia"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2834-9047","authenticated-orcid":true,"given":"Carolina","family":"V\u00e1zquez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Laura","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Ferraris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Bandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9912-9503","authenticated-orcid":true,"given":"Marcelo Mart\u00edn","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,2,7]]},"reference":[{"key":"pone.0228486.ref001","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/jmg.2009.069013","article-title":"International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia","volume":"48","author":"ME Faughnan","year":"2011","journal-title":"J Med Genet"},{"key":"pone.0228486.ref002","article-title":"The prevalence and manifestations of hereditary hemorrhagic telangiectasia in the Afro-Caribbean population of the Netherlands Antilles: A family screening","author":"CJJ Westermann","year":"2003","journal-title":"Am J Med Genet"},{"key":"pone.0228486.ref003","unstructured":"Serra MM, Franceschini C PJ. First prevalence report of hereditary hemorrhagic telangiectasia in a Latin American population. HHT International Scientific Conference 2015. Captiva, Florida, USA. Angiogenesis. 2015;18: 525\u201375."},{"key":"pone.0228486.ref004","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","article-title":"Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)","volume":"91","author":"CL Shovlin","year":"2000","journal-title":"Am J Med Genet"},{"key":"pone.0228486.ref005","article-title":"Diagnosis and management of gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia","author":"V. Longacre A","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"pone.0228486.ref006","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1007\/s10620-011-1585-2","article-title":"Natural history and outcome of hepatic vascular malformations in a large cohort of patients with hereditary hemorrhagic teleangiectasia","volume":"56","author":"E Buscarini","year":"2011","journal-title":"Dig Dis Sci"},{"key":"pone.0228486.ref007","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2006.12.008","article-title":"Liver involvement in hereditary hemorrhagic telangiectasia (HHT)","volume":"46","author":"G. Garcia-Tsao","year":"2007","journal-title":"J Hepatol"},{"key":"pone.0228486.ref008","article-title":"A Review on Clinical Management and Pharmacological Therapy on Hereditary Haemorrhagic Telangiectasia (HHT)","author":"R Zarrabeitia","year":"2010","journal-title":"Curr Vasc Pharmacol"},{"key":"pone.0228486.ref009","article-title":"Treatment of epistaxis in hereditary hemorrhagic telangiectasia with tranexamic acid\u2014A double-blind placebo-controlled cross-over phase IIIB study","author":"UW Geisthoff","year":"2014","journal-title":"Thromb Res"},{"key":"pone.0228486.ref010","article-title":"Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: A European cross-over controlled trial in a rare disease","author":"S Gaillard","year":"2014","journal-title":"J Thromb Haemost"},{"key":"pone.0228486.ref011","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1160\/TH09-07-0425","article-title":"Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells","volume":"103","author":"V Albinana","year":"2010","journal-title":"Thromb Haemost"},{"key":"pone.0228486.ref012","article-title":"Tacrolimus rescues the signaling and gene expression signature of endothelial ALK1 loss-of-function and improves HHT vascular pathology","author":"S Ruiz","year":"2017","journal-title":"Hum Mol Genet"},{"key":"pone.0228486.ref013","article-title":"Treatment with low-dose tacrolimus inhibits bleeding complications in a patient with hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension","author":"N Sommer","year":"2019","journal-title":"Pulm Circ"},{"key":"pone.0228486.ref014","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1160\/TH11-11-0809","article-title":"Propranolol as antiangiogenic candidate for the therapy of hereditary haemorrhagic telangiectasia","volume":"108","author":"V Albinana","year":"2012","journal-title":"Thromb Haemost"},{"key":"pone.0228486.ref015","article-title":"Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia","author":"L Ruiz-Llorente","year":"2017","journal-title":"Expert Opinion on Therapeutic Targets"},{"key":"pone.0228486.ref016","article-title":"The use of thalidomide therapy for refractory epistaxis in hereditary haemorrhagic telangiectasia: Systematic review","author":"L Harrison","year":"2018","journal-title":"Journal of Laryngology and Otology"},{"key":"pone.0228486.ref017","article-title":"Pazopanib may reduce bleeding in hereditary hemorrhagic telangiectasia","author":"ME Faughnan","year":"2019","journal-title":"Angiogenesis"},{"key":"pone.0228486.ref018","first-page":"340","article-title":"Long-term outcome of patients with hereditary hemorrhagic telangiectasia and severe hepatic involvement after orthotopic liver transplantation: a single-center study","volume":"16","author":"S Dupuis-Girod","year":"2010","journal-title":"Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"pone.0228486.ref019","article-title":"Liver transplantation for hereditary hemorrhagic telangiectasia: Report of the European liver transplant registry","author":"J Lerut","year":"2006","journal-title":"Ann Surg"},{"key":"pone.0228486.ref020","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/hep.22672","article-title":"Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: in search of predictors of significant disease","author":"G Garcia-Tsao","year":"2008","journal-title":"Hepatology"},{"key":"pone.0228486.ref021","article-title":"Vascular endothelial growth factor serum levels are elevated in patients with hereditary hemorrhagic telangiectasia","author":"A Cirulli","year":"2003","journal-title":"Acta Haematol"},{"key":"pone.0228486.ref022","first-page":"818","article-title":"Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression","volume":"90","author":"H Sadick","year":"2005","journal-title":"Haematologica"},{"key":"pone.0228486.ref023","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1111\/liv.13210","article-title":"Hereditary hemorrhagic telangiectasia: to transplant or not to transplant","volume":"36","author":"S Dupuis-Girod","year":"2016","journal-title":"Liver Int"},{"key":"pone.0228486.ref024","article-title":"Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output","author":"S Dupuis-Girod","year":"2012","journal-title":"JAMA\u2014J Am Med Assoc"},{"key":"pone.0228486.ref025","article-title":"Intra-venous bevacizumab in hereditary hemorrhagic telangiectasia (HHT): A retrospective study of 46 patients","author":"A Guilhem","year":"2017","journal-title":"PLoS One"},{"key":"pone.0228486.ref026","article-title":"Intravenous Bevacizumab for Refractory Hereditary Hemorrhagic Telangiectasia\u2013Related Epistaxis and Gastrointestinal Bleeding","author":"VN Iyer","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"pone.0228486.ref027","doi-asserted-by":"crossref","first-page":"S701","DOI":"10.1016\/S0016-5085(18)32472-7","article-title":"Tine Rosenberg ADK. Bevacizumab as Treatment of Bleeding in Patients with Hereditary Haemorrhagic Telangiectasia (HHT)","volume":"154","author":"Jens Kjeldsen","year":"2018","journal-title":"Gastroenterology"},{"key":"pone.0228486.ref028","first-page":"301","article-title":"Intravenous iron-dextran: therapeutic and experimental possibilities","volume":"100","author":"AM Ganzoni","year":"1970","journal-title":"Schweiz Med Wochenschr"},{"key":"pone.0228486.ref029","article-title":"An epistaxis severity score for hereditary hemorrhagic telangiectasia","author":"JB Hoag","year":"2010","journal-title":"Laryngoscope"},{"key":"pone.0228486.ref030","article-title":"VEGF expands erythropoiesis via hypoxia-independent induction of erythropoietin in noncanonical perivascular stromal cells","author":"AC Greenwald","year":"2019","journal-title":"J Exp Med"},{"key":"pone.0228486.ref031","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1111\/liv.13187","article-title":"Hereditary haemorrhagic telangiectasia: to transplant or not to transplant\u2014is there a right time for liver transplantation?","volume":"36","author":"YD Muller","year":"2016","journal-title":"Liver Int"},{"key":"pone.0228486.ref032","article-title":"Executive summary of the 12th HHT international scientific conference","author":"JW Andrejecsk","year":"2018","journal-title":"Angiogenesis"},{"key":"pone.0228486.ref033","article-title":"Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia","author":"A Mitchell","year":"2008","journal-title":"Liver Transplant"},{"key":"pone.0228486.ref034","doi-asserted-by":"crossref","unstructured":"Gonzalez, ML; Arguero, MJ; Serra M. A new kind of digestive arteriovenous malformation after endoscopic treatment in HHT patients. A second hit consequence? A case report. 12th International HHT Scientific Conference. Angiogenesis. 2018. doi: 10.1007\/s10456-017-9584-3","DOI":"10.1007\/s10456-017-9584-3"},{"key":"pone.0228486.ref035","doi-asserted-by":"crossref","first-page":"e1966","DOI":"10.1097\/MD.0000000000001966","article-title":"Bevacizumab to Treat Cholangiopathy in Hereditary Hemorrhagic Telangiectasia: Be Cautious: A Case Report","volume":"94","author":"Q Maestraggi","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"pone.0228486.ref036","article-title":"MMP-12, Secreted by Pro-Inflammatory Macrophages, Targets Endoglin in Human Macrophages and Endothelial Cells","author":"M Aristorena","year":"2019","journal-title":"Int J Mol Sci"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0228486","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T13:29:21Z","timestamp":1581082161000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0228486"}},"subtitle":[],"editor":[{"given":"Pavel","family":"Strnad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,2,7]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0228486","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,7]]}}}